Fresenius Kabi Austria GmbH
Fresenius Kabi Austria GmbH is listed as the manufacturer on 2 FDA drug label records covering 2 distinct active ingredients predominantly human prescription drug products.
About Fresenius Kabi Austria GmbH
Fresenius Kabi Austria GmbH is named as the labeler on 2 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by CLEVIDIPINE, LACTULOSE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: reduction blood, oral therapy, portal-systemic encephalopathy, controlled studies, usage cleviprex, dihydropyridine calcium, channel blocker, stages hepatic. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| CLEVIDIPINE | 1 |
| LACTULOSE | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 1 |
| — | — | ORAL | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Fresenius Kabi Austria GmbH
Frequently asked questions
How many FDA drug products does Fresenius Kabi Austria GmbH make?
2 FDA drug label records name Fresenius Kabi Austria GmbH as the manufacturer, covering 2 distinct active ingredients.
What active ingredients does Fresenius Kabi Austria GmbH produce?
The most frequent active ingredients in this portfolio are CLEVIDIPINE, LACTULOSE.
Are Fresenius Kabi Austria GmbH products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.